UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Macrogen wins patent for fusion genes that causes lung adenocarcinoma
by Lee Han-soo
2019-10-28 17:08
Hanall posts ₩28 billion in Q3 sales
by Lee Han-soo
2019-10-28 17:08
'Development of new psoriasis treatments good news for patients'
by Lee Han-soo
2019-10-28 13:56
Korea should import new drug to treat pulmonary arterial hypertension
by Kim Yun-mi
2019-10-25 18:08
Hanmi’s US partner resubmits BLA application for neutropenia treatment
by Lee Han-soo
2019-10-25 17:36
라인
'Pharmacovigilance as crucial as clinical trials'
by Lee Han-soo
2019-10-24 18:21
Daewoong releases trial data on gastroesophageal reflux disease drug
by Lee Han-soo
2019-10-24 17:00
Novartis’ Cosentyx strengthens position as comprehensive psoriasis treatment
by Lee Han-soo
2019-10-24 14:47
AbbVie draws favorable rating for its rheumatism drug in Europe
by Lee Han-soo
2019-10-24 14:45
PharmAbcine sets up US unit to develop anticancer drug
by Jeong Sae-im
2019-10-23 15:48
라인
Pfizer Korea reaffirms corporate missions on 50th anniversary
by Lee Han-soo
2019-10-23 14:53
Gemvax & Kael's GV1001 shows efficacy as prostate cancer treatment
by Lee Han-soo
2019-10-23 10:59
Pfizer’s atopic drug should overcome side effects to challenge Sanofi’s Dupixent
by Kim Yun-mi
2019-10-22 14:17
Pharma industry hits government steps regarding ranitidine ban
by Lee Han-soo
2019-10-21 17:16
Dong-A ST leaves KPBMA to ‘repent of illegal rebate’
by Jeong Sae-im
2019-10-21 16:42
라인
GSK applies for additional indication of asthma inhaler Trelegy Ellipta
by Lee Han-soo
2019-10-21 15:32
Drug firms’ Q3 earnings to be fairly good
by Jeong Sae-im
2019-10-21 12:27
Regulator OKs Jeil's advanced colorectal cancer treatment
by Lee Han-soo
2019-10-21 11:38
Ministry OKs ATGC's p1, 2 trial for BTX
by Lee Han-soo
2019-10-18 18:23
Physicians feel burdened by Ranitidine ban: survey
by Lee Han-soo
2019-10-18 16:48
-
이전
21
22
23
24
25
26
27
28
29
30
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top